These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 24510513

  • 1. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y, Zhou T, Zhu J, Zhang Y, Sun M, Ding X, Wang D, Li H, Li B.
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [Abstract] [Full Text] [Related]

  • 2. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1335-42. PubMed ID: 18922648
    [Abstract] [Full Text] [Related]

  • 3. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
    Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY.
    J Clin Oncol; 2006 Apr 20; 24(12):1904-9. PubMed ID: 16622266
    [Abstract] [Full Text] [Related]

  • 4. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.
    Petsuksiri J, Sermsree A, Thephamongkhol K, Keskool P, Thongyai K, Chansilpa Y, Pattaranutaporn P.
    Radiat Oncol; 2011 Feb 20; 6():19. PubMed ID: 21333025
    [Abstract] [Full Text] [Related]

  • 5. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
    Yip PL, Mok KCJ, Ho HS, Lee WYV, Wong ACL, Lau CT, Wong FCS, Yeung KW, Lee SF.
    Clin Oncol (R Coll Radiol); 2022 Apr 20; 34(4):e160-e167. PubMed ID: 34772581
    [Abstract] [Full Text] [Related]

  • 6. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819
    [Abstract] [Full Text] [Related]

  • 7. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am Zehnhoff-Dinnesen A, Eich HT.
    Strahlenther Onkol; 2017 Nov 01; 193(11):910-920. PubMed ID: 28887665
    [Abstract] [Full Text] [Related]

  • 8. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL.
    Cancer; 2006 Feb 15; 106(4):820-9. PubMed ID: 16421885
    [Abstract] [Full Text] [Related]

  • 9. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Zhu W, Chen F, Li J, Wang W, Zhang H, Yang G, Zou L, Zhu Y, Yuan W, Ding H, Song X, Wang S.
    Acta Otolaryngol; 2019 Mar 15; 139(3):263-268. PubMed ID: 30870056
    [Abstract] [Full Text] [Related]

  • 10. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.
    Oh YT, Kim CH, Choi JH, Kang SH, Chun M.
    Radiother Oncol; 2004 Jul 15; 72(1):79-82. PubMed ID: 15236878
    [Abstract] [Full Text] [Related]

  • 11. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
    Theunissen EA, Bosma SC, Zuur CL, Spijker R, van der Baan S, Dreschler WA, de Boer JP, Balm AJ, Rasch CR.
    Head Neck; 2015 Feb 15; 37(2):281-92. PubMed ID: 24478269
    [Abstract] [Full Text] [Related]

  • 12. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
    Mahdavi SR, Rezaeyan A, Nikoofar A, Bakhshandeh M, Farahani S, Cheraghi S.
    J Cancer Res Ther; 2020 Feb 15; 16(3):539-545. PubMed ID: 32719264
    [Abstract] [Full Text] [Related]

  • 13. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.
    Chen Y, Sun Y, Liang SB, Zong JF, Li WF, Chen M, Chen L, Mao YP, Tang LL, Guo Y, Lin AH, Liu MZ, Ma J.
    Cancer; 2013 Jun 15; 119(12):2230-8. PubMed ID: 23576020
    [Abstract] [Full Text] [Related]

  • 14. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N, Kaushal D, Patro SK, Pareek P, Dixit A, Soni K, Prakasan Nair N, Choudhury B, Goyal A.
    Acta Otolaryngol; 2021 Sep 15; 141(9):885-893. PubMed ID: 34486907
    [Abstract] [Full Text] [Related]

  • 15. Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.
    Hwang CF, Fang FM, Zhuo MY, Yang CH, Yang LN, Hsieh HS.
    Biomed Res Int; 2015 Sep 15; 2015():769806. PubMed ID: 26351638
    [Abstract] [Full Text] [Related]

  • 16. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
    Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, Au DK, Wu PM, Choy DT.
    Int J Radiat Oncol Biol Phys; 1996 Sep 01; 36(2):281-9. PubMed ID: 8892450
    [Abstract] [Full Text] [Related]

  • 17. Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma.
    Wakisaka H, Yamada H, Motoyoshi K, Ugumori T, Takahashi H, Hyodo M.
    Auris Nasus Larynx; 2011 Feb 01; 38(1):95-100. PubMed ID: 20541337
    [Abstract] [Full Text] [Related]

  • 18. Effect of radiotherapy on retro-cochlear auditory pathways.
    Low WK, Burgess R, Fong KW, Wang DY.
    Laryngoscope; 2005 Oct 01; 115(10):1823-6. PubMed ID: 16222203
    [Abstract] [Full Text] [Related]

  • 19. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
    Espenel S, Garcia MA, Guy JB, Vallard A, Ben Mrad M, Langrand-Escure J, El Meddeb Hamrouni A, Trone JC, Xia Y, Rancoule C, Magné N.
    Cancer Radiother; 2017 Feb 01; 21(1):77-83. PubMed ID: 28189351
    [Abstract] [Full Text] [Related]

  • 20. Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
    Atchariyasathian V, Pruegsanusak K, Wongsriwattanakul S.
    J Laryngol Otol; 2015 Aug 01; 129(8):767-72. PubMed ID: 26112091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.